Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Hashimoto J et al. – 4–hydro–3–methoxyacetophenone and 5–nitrosalicylaldehyde may be useful as a lead compound of anti–type 2 diabetic drugs.

Related Articles

Sodium Glucose Cotransporter 2 Inhibitors as a New Treatment for Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 11/10/09    Relevance Score: 90%

Evidence for an association with type 2 diabetes mellitus at the PPARG locus in a South Indian population
Metabolism-Clinical and Experimental, 11/03/09    Relevance Score: 90%

A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus
Pharmacotherapy, 10/28/09    Relevance Score: 90%

Hepatic fat and inflammation in type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09    Relevance Score: 90%

Design of a family-based lifestyle intervention for youth with type 2 diabetes: the TODAY study
International Journal of Obesity, 10/16/09    Relevance Score: 90%

Today in Diabetes...keeping you current

New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09

Consumption of restaurant foods and incidence of type 2 diabetes in African American women
American Journal of Clinical Nutrition, 12/18/09

Gestational diabetes mellitus: an opportunity to prevent Type 2 diabetes and cardiovascular disease in young women
Women's Health, 12/18/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address